Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, October 28, 2013

BioTime Reports Interim Results on Reneviaa Clinical Safety Trial

BioTime, Inc. , today announced that William Tew, Ph.D., BioTime's Chief Commercial Officer will provide an update on the development of Renevia a at an investor meeting in New York City.

http://www.businesswire.com/news/topix/20131028005633/en
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts